2025.08.20Development

HGF Gene Therapy Product: AnGes and Boehringer Enter Manufacturing Collaboration

2025.08.08IR

Decision on the Development Policy for the HGF Gene Therapy Product in the United States and Regarding the Contract with Boehringer Ingelheim Biopharmaceuticals Notification Regarding the Drug Substance Supply Agreement

2025.08.08IR

Consolidated Financial Report for the Second Quarter 2025

2025.05.26Development

Notice on Publication on the Paper of Results of Late Phase I Clinical Trial of NF-κB Decoy Oligo DNA for the Treatment of Chronic Intervertebral Disc Lumbago in the US

2025.05.09IR

Consolidated Financial Report for the First Quarter 2025

Learn more